Drugmakers Try Evasion, Tougher Negotiations to Fight New U.S. Insurer Tactic

Published on 5 Jul 2018, 16:14
On Thursday Reuters reported that major pharmaceutical companies are scrambling to limit the economic damage from a new U.S. insurer tactic that coaxes patients away from expensive drugs. The latest move by insurers - which effectively forces drug companies to pay more to assist patients with their copays - is causing a decline in real U.S. drug prices this year. Reuters reported that drugmakers are working on ways to counter copay accumulator programs, fearing that more employer health plans will adopt them in 2019.

This video was produced by YT Wochit News using wochit.com